KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Shares Repurchased (2018 - 2023)

Astrana Health (ASTH) has disclosed Shares Repurchased for 7 consecutive years, with $503000.0 as the latest value for Q4 2023.

  • Quarterly Shares Repurchased rose 226.38% to $503000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $10.2 million through Dec 2023, up 12.22% year-over-year, with the annual reading at $10.2 million for FY2023, 10.18% up from the prior year.
  • Shares Repurchased hit $503000.0 in Q4 2023 for Astrana Health, up from $150000.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $9.5 million in Q2 2023 to a low of -$1.0 million in Q4 2020.
  • Historically, Shares Repurchased has averaged $2.2 million across 5 years, with a median of $426000.0 in 2020.
  • Biggest YoY gain for Shares Repurchased was 965.0% in 2020; the steepest drop was 113.57% in 2020.
  • Year by year, Shares Repurchased stood at $7.5 million in 2019, then crashed by 113.57% to -$1.0 million in 2020, then surged by 369.86% to $2.8 million in 2021, then tumbled by 114.43% to -$398000.0 in 2022, then surged by 226.38% to $503000.0 in 2023.
  • Business Quant data shows Shares Repurchased for ASTH at $503000.0 in Q4 2023, $150000.0 in Q3 2023, and $9.5 million in Q2 2023.